Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Journal of Environmental Pathology, Toxicology and Oncology
Импакт фактор: 1.625 5-летний Импакт фактор: 1.63 SJR: 0.402 SNIP: 0.613 CiteScore™: 2.3

ISSN Печать: 0731-8898
ISSN Онлайн: 2162-6537

Выпуски:
Том 39, 2020 Том 38, 2019 Том 37, 2018 Том 36, 2017 Том 35, 2016 Том 34, 2015 Том 33, 2014 Том 32, 2013 Том 31, 2012 Том 30, 2011 Том 29, 2010 Том 28, 2009 Том 27, 2008 Том 26, 2007 Том 25, 2006 Том 24, 2005 Том 23, 2004 Том 22, 2003 Том 21, 2002 Том 20, 2001

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i3.30
pages 191-196

Modern Concepts of the Diagnosis and Treatment of Purpura Fulminans

Richard Edlich
Legacy Verified Level I Shock Trauma Center Pediatrics and Adults, Legacy Emanual Hospital; and Plastic Surgery, Biomedical Engineering and Emergency Medicine, University of Virginia Health System, USA
Catherine L. Cross
Legacy Emanuel Hospital, Portland, OR, USA
Jill J. Dahlstrom
Legacy Verified Level I Shock Trauma Center, Legacy Emanuel Hospital, Portland, OR, USA
William B. Long III
Trauma Specialists LLP, Legacy Verified Level I Shock Trauma Center for Pediatrics and Adults, Legacy Emmanuel Hospital Portland, OR, USA

Краткое описание

Purpura fulminans is a rare syndrome of intravascular thrombosis and hemorrhagic infarction of the skin that is rapidly progressive and accompanied by vascular collapse and disseminated intravascular coagulation. It usually occurs in children, but this syndrome has also been noted in adults. The purpose of this collective review is to provide modern concepts on the diagnosis and treatment of neonatal purpura fulminans, idiopathic purpura fulminans, and acute infectious purpura fulminans. There are three forms of this disease that are classified by the triggering mechanisms. First, neonatal purpura fulminans is associated with a hereditary deficiency of the natural anticoagulants Protein C and Protein S as well as Antithrombin III. Idiopathic purpura fulminans usually follows an initiating febrile illness that manifests with rapidly progressive purpura. Deficiency of Protein S is considered to be central to the pathogenesis of this form of the disease. The third and most common type of purpura fulminans is acute infectious purpura fulminans. The mortality rate has decreased with better treatment of secondary infections, supportive care, and new treatments, but it remains a disabling condition often requiring major amputations.


Articles with similar content:

Massive Soft Tissue Infections: Necrotizing Fasciitis and Purpura Fulminans
Journal of Long-Term Effects of Medical Implants, Vol.15, 2005, issue 1
William B. Long III, Richard Edlich, Kathryne L. Winters, L. D. Britt, Charles R. Woodard
Obstructive Sleep Apnea: Part I. Pathophysiology, Diagnosis, and Medical Management
Journal of Long-Term Effects of Medical Implants, Vol.14, 2004, issue 3
Steven M. Koenig, James J. Carswell
Genome-Wide Association Studies and Infectious Disease
Critical Reviews™ in Immunology, Vol.30, 2010, issue 3
Anne M. Bowcock
Nerve Injuries around the Shoulder
Journal of Long-Term Effects of Medical Implants, Vol.27, 2017, issue 1
Panayiotis D. Megaloikonomos, Zinon T. Kokkalis, Andreas F. Mavrogenis, Ilias D. Iliopoulos, Nikolaos Pantzaris, Elias Panagiotopoulos
Evaluation and Management of Neurogenic Bladder in Persons with Spinal Cord Injury
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.12, 2000, issue 2
Sally A. Holmes, Timothy B. Boone, Jennifer Harrison